Clinical Research Directory
Browse clinical research sites, groups, and studies.
Ischemic Postconditioning in STEMI Patients Treated With Primary PCI
Sponsor: Rigshospitalet, Denmark
Summary
In a prospective, randomized clinical trial the iPOST2 trial will determine whether ischemic postconditioning reduces reperfusion injury and this will translate into improved clinical outcome of heart failure and death for STEMI patients who present with TIMI0-1 undergoing primary PCI
Official title: The Effect of Ischemic Postconditioning in Patients With STEMI Undergoing Primary PCI (DANAMI4-iPOST2)
Key Details
Gender
All
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
1800
Start Date
2019-02-04
Completion Date
2033-01-31
Last Updated
2026-03-30
Healthy Volunteers
No
Interventions
Ischemic postconditioning
After 60 seconds of reperfusion, ischemic postconditioning with an adequately sized balloon (60 reperfusion/60 seconds re-occlusion, four cycles) will be performed
Conventional
State of the art primary PCI, however thrombectomy is not allowed
Locations (1)
The Heart Center, Rigshospitalet, University of Copenhagen
Copenhagen, Denmark